Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: Analysis of mRNA expression of fluoropyrimidine metabolism enzymes in the primary tumor

International Journal of Clinical Oncology

Volumn 14, Issue 3, 2009, Pages 245-248

  Matsuda, Masanori ^a   Shiba, Shugo ^a   Asakawa, Masami ^a   Kono, Hiroshi ^a   Fujii, Hideki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Complete remission; Fluoropyrimidine metabolism enzymes; Hepatocellular carcinoma; Tegafur uracil

Indexed keywords

FLUOROPYRIMIDINE; MESSENGER RNA; THYMIDINE PHOSPHORYLASE; UFT; DIHYDROPYRIMIDINE DEHYDROGENASE; OROTATE PHOSPHORIBOSYLTRANSFERASE; TEGAFUR; THYMIDYLATE SYNTHASE; URACIL;

ADULT; ANAMNESIS; ARTICLE; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; JAPANESE; LABORATORY TEST; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MALE; PEROPERATIVE ECHOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT CANCER; TUMOR THROMBUS; CHEMOEMBOLIZATION; ENZYMOLOGY; GENETICS; LIVER TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PATHOLOGY; TUMOR RECURRENCE;

ADMINISTRATION, ORAL; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DIHYDROURACIL DEHYDROGENASE (NADP); HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OROTATE PHOSPHORIBOSYLTRANSFERASE; RNA, MESSENGER; TEGAFUR; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; URACIL; VENA CAVA, INFERIOR;

EID: 70349560343     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-008-0820-0     Document Type: Article

References (13)

1. T. Ishikawa T. Ichida Y. Ishimoto, et al. 1999 Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil Am J Gastroenterol 94 1682 1685 10364045 10.1111/j.1572-0241. 1999.01163.x 1:STN:280:DyaK1M3ptVOisQ%3D%3D (Pubitemid 29260466)
2. T. Ishikawa T. Ichida S. Sugitani, et al. 2001 Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma J Gastroenterol Hepatol 16 452 459 11354285 10.1046/j.1440-1746.2001.02352.x 1:CAS:528:DC%2BD3MXktVOhsrk%3D (Pubitemid 32397659)
3. Y. Matsumoto H. Fujii M. Matsuda, et al. 2001 Multicentric occurrence of hepatocellular carcinoma: diagnosis and clinical significance J Hepatobiliary Pancreat Surg 8 435 440 11702253 10.1007/s005340100006 1:STN:280: DC%2BD3MnkvVemtw%3D%3D
4. Liver Cancer Study Group of Japan (2008) The general rules for the clinical and pathological study of primary liver cancer, 5th edn. Kanehara, Tokyo
5. T. Horikoshi K.D. Danenberg T.H. Stadlbauer, et al. 1992 Quantitation of thymidylate synthase, dihydrofolate reductase, and DTdiaphorase gene expression in human tumors using the polymerase chain reaction Cancer Res 52 108 116 1727369 1:CAS:528:DyaK38Xls1Gjsw%3D%3D
6. D. Salonga K.D. Danenberg M. Johnson, et al. 2000 Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase Clin Cancer Res 6 1322 1327 10778957 1:CAS:528: DC%2BD3cXjtVOqt74%3D
7. W. Ichikawa H. Uetake Y. Shirota, et al. 2003 Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine- based chemotherapy for metastatic colorectal cancer Clin Cancer Res 9 786 791 12576451 1:CAS:528:DC%2BD3sXhtVKksbo%3D
8. M. Kornmann W. Schwabe S. Sander, et al. 2003 Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil Clin Cancer Res 9 4116 4124 14519634 1:CAS:528:DC%2BD3sXns1OjtLY%3D
9. T. Takahashi H. Yoshida Y. Mamada, et al. 2007 Profiling of fluorouracil-related genes by microdissection technique in hepatocellular carcinoma Hepatogastroenterology 54 1612 1616 18019677 1:CAS:528: DC%2BD2sXhtlektLnO
10. W. Ichikawa H. Uetake Y. Shirota, et al. 2003 Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer Br J Cancer 89 1486 1492 14562021 10.1038/sj.bjc.6601335 1:CAS:528:DC%2BD3sXotFektr0%3D (Pubitemid 37386604)
11. K. Miyake S. Imura T. Yoshizumi, et al. 2007 Role of thymidine phosphorylase and orotate phosphoribosyltransferase mRNA expression and its ratio to dihydropyrimidine dehydrogenase in the prognosis and clinicopathological features of patients with pancreatic cancer Int J Clin Oncol 12 111 119 17443278 10.1007/s10147-006-0634-x 1:CAS:528:DC%2BD2sXktlOgsrs%3D (Pubitemid 46632459)
12. G.S. Chan W.K. Ng I.O. Ng, et al. 2000 Sudden death from massive pulmonary tumor embolism due to hepatocellular carcinoma Forensic Sci Int 108 215 221 10737468 10.1016/S0379-0738(99)00212-1 1:STN:280:DC%2BD3c7pvFOhuw%3D%3D (Pubitemid 30085553)
13. I. Ikai Y. Yamaoka Y. Yamamoto, et al. 1998 Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy Ann Surg 227 433 439 9527067 10.1097/00000658-199803000-00016 1:STN:280:DyaK1c7os1aqtA%3D%3D (Pubitemid 28131025)